Smith MS - Search Results

1

Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR.

Markovitz DM, Kenney S, Kamine J, Smith MS, Davis M, Huang ES, Rosen C, Pagano JS. Markovitz DM, et al. Among authors: smith ms. Virology. 1989 Dec;173(2):750-4. doi: 10.1016/0042-6822(89)90591-6. Virology. 1989. PMID: 2556854

2

The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.

Quinlivan EB, Holley-Guthrie E, Mar EC, Smith MS, Kenney S. Quinlivan EB, et al. Among authors: smith ms. J Virol. 1990 Apr;64(4):1817-20. doi: 10.1128/JVI.64.4.1817-1820.1990. J Virol. 1990. PMID: 2157062 Free PMC article.

3

Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.

Smith MS, Brian EL, Pagano JS. Smith MS, et al. J Virol. 1987 Dec;61(12):3769-73. doi: 10.1128/JVI.61.12.3769-3773.1987. J Virol. 1987. PMID: 2446006 Free PMC article.

4

Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells.

Smith MS, Koerber KL, Pagano JS. Smith MS, et al. J Infect Dis. 1993 Feb;167(2):445-8. doi: 10.1093/infdis/167.2.445. J Infect Dis. 1993. PMID: 7678429

5

Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.

Smith MS, Thresher RJ, Pagano JS. Smith MS, et al. Antimicrob Agents Chemother. 1991 Jan;35(1):62-7. doi: 10.1128/AAC.35.1.62. Antimicrob Agents Chemother. 1991. PMID: 1707604 Free PMC article.

6

Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.

Smith MS, Brian EL, De Clercq E, Pagano JS. Smith MS, et al. Antimicrob Agents Chemother. 1989 Sep;33(9):1482-6. doi: 10.1128/AAC.33.9.1482. Antimicrob Agents Chemother. 1989. PMID: 2479334 Free PMC article.

7

Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy.

Smith MS, Koerber KL, Pagano JS. Smith MS, et al. J Infect Dis. 1994 Jan;169(1):184-8. doi: 10.1093/infdis/169.1.184. J Infect Dis. 1994. PMID: 7506280 Clinical Trial.

8

Long-term persistence of AZT-resistance mutations in the plasma HIV-1 of patients removed from AZT therapy.

Smith MS, Koerber KL, Pagano JS. Smith MS, et al. Leukemia. 1994 Apr;8 Suppl 1:S179-82. Leukemia. 1994. PMID: 8152287

9

Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.

Smith MS, Kessler JA, Rankin CD, Pagano JS, Kurtzberg J, Carter SG. Smith MS, et al. Antimicrob Agents Chemother. 1993 Jan;37(1):144-7. doi: 10.1128/AAC.37.1.144. Antimicrob Agents Chemother. 1993. PMID: 8431013 Free PMC article.

10

Subclinical central nervous system infection with JC virus in patients with AIDS.

Quinlivan EB, Norris M, Bouldin TW, Suzuki K, Meeker R, Smith MS, Hall C, Kenney S. Quinlivan EB, et al. Among authors: smith ms. J Infect Dis. 1992 Jul;166(1):80-5. doi: 10.1093/infdis/166.1.80. J Infect Dis. 1992. PMID: 1318912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters